Acadia Healthcare Company, Inc. ACHC
Acadia Healthcare Company, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.3B | $3.2B | $2.9B | $2.6B | $2.3B | $2.1B | $2.0B | $1.9B | $2.8B | $2.8B |
| Operating income | — | — | — | — | — | — | $585.9M | $593.6M | $604.4M | $608.6M |
| Income tax | $26.0M | $77.4M | -$9.7M | $94.1M | $67.6M | $40.6M | $25.1M | $9.9M | $37.2M | $28.8M |
| Net income | -$1.1B | $255.6M | -$21.7M | $273.1M | $190.6M | -$672.1M | $108.9M | -$175.8M | $199.8M | $6.1M |
| EPS (diluted) | $-12.16 | $2.78 | $-0.24 | $2.98 | $2.10 | $-7.59 | $1.24 | $-2.01 | $2.30 | $0.07 |
| Operating cash flow | $131.9M | $129.7M | $462.3M | $380.6M | $374.5M | $658.8M | $332.9M | $414.1M | $401.3M | $371.7M |
| Free cash flow | -$439.9M | -$560.7M | $38.2M | $84.4M | $129.7M | $433.8M | $100.2M | $160.9M | $127.1M | $64.3M |
| Cash & equivalents | $133.2M | $76.3M | $100.1M | $97.6M | $133.8M | $378.7M | $99.5M | $50.5M | $67.3M | $57.1M |
| Inventory | $5.7M | $5.7M | $5.3M | $5.1M | $4.8M | $4.9M | $4.1M | $5.1M | $4.8M | $4.6M |
| Total assets | $5.5B | $6.0B | $5.4B | $5.0B | $4.8B | $6.5B | $6.9B | $6.2B | $6.4B | $6.0B |
| Total liabilities | $3.4B | $2.8B | $2.5B | $2.1B | $2.2B | $4.5B | $4.3B | $3.8B | $3.8B | $3.8B |
| Shareholders' equity | $1.9B | $3.1B | $2.8B | $2.8B | $2.5B | $1.9B | $2.5B | $2.3B | $2.6B | $2.2B |
Growth · year-over-year · Revenue CAGR 1.8%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +5.0% | +7.7% | +12.2% | +12.8% | +10.7% | +4.1% | +5.4% | -32.8% | +0.9% | — |
| Net income growth | -531.4% | — | -107.9% | +43.3% | — | -717.1% | — | -187.9% | +3153.1% | -94.5% |
| EPS growth | -537.4% | — | -108.1% | +41.9% | — | -712.1% | — | -187.4% | +3185.7% | -95.7% |
| Free cash flow growth | — | -1567.5% | -54.7% | -34.9% | -70.1% | +332.9% | -37.7% | +26.6% | +97.8% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.